Likewise, Sanoyama et al. showed that REV-7 plays an important role in small-cell lung cancer cell survival and proliferation, once again emphasizing the potential therapeutic properties of REV-7 inactivation, possibly through blockage of the TLS pathway, in esophageal SCCs [18]. The gene discussed is MAD2L2; the disease is small cell lung carcinoma.